More than 50 million adults in the United States live with chronic pain, according to the Centers for Disease Control and Prevention. For many of them, the original injury healed long ago. The nerves repaired, the tissue closed, the scans came back clean. Yet the pain stayed. A growing body of neuroscience research is now offering an explanation: the problem may not be in the body at all, but in a brain circuit that never got the message to stop.
In a study published in May 2026 in The Journal of Neuroscience, researchers at the University of Colorado Boulder identified a specific neural pathway that appears to act as a gating mechanism for chronic pain in animal models. The pathway runs from a small strip of tissue called the caudal granular insular cortex, or CGIC, deep in the brain’s insular cortex, to the primary somatosensory cortex, the region that processes touch and body sensation. When the team toggled this connection on and off in rats with sciatic nerve injuries, the animals’ pain behaviors changed dramatically.
A cortical feedback loop that maintains chronic pain
The study was led by first author Jayson Ball and senior author Linda Watkins. Using a fluorescent labeling tool called mGreenLantern, the team traced the physical wiring from the CGIC to the somatosensory cortex. They then used chemogenetic tools called DREADDs, which allow researchers to activate or silence specific neurons using a specially designed compound, to test what happened when they manipulated that connection.
In rats that had undergone nerve injury, silencing the pathway reduced allodynia, a condition in which ordinary, painless touch becomes excruciating. Activating it made pain behaviors worse. Watkins described the CGIC as a “decision point” for whether pain signals keep firing long after tissue has healed. Ball outlined the proposed chain of events: signals travel from the CGIC to the somatosensory cortex and then loop back down to the spinal cord, creating a top-down feedback circuit that can sustain pain independently of the original injury.
This finding builds on earlier work from the same lab. A 2011 study, also published in The Journal of Neuroscience, showed that targeting the CGIC produced long-lasting relief from allodynia in a rat neuropathic pain model. That paper established that a discrete cortical subregion could gate persistent pain-like behavior. The new study extends the finding by mapping exactly where the CGIC sends its signals downstream.
Other teams are finding the same pattern
The Colorado team is not working in isolation. A separate group published a study in Nature that mapped a multi-synaptic feedback loop in mice running from the spinal cord to the thalamus, through the somatosensory cortex, into subcortical and brainstem relay stations, and back to the spinal cord. Using silencing and activation at each node, the researchers showed this loop was both necessary and sufficient for injury-induced mechanical hypersensitivity. The overlap is hard to miss: both studies place the somatosensory cortex at the center of a feedback circuit capable of sustaining pain in a chronic state.
Additional circuit-level research fills in other pieces. A study in Nature identified a parabrachial hub in mice that modulates lasting pain through motivational and need-state interactions, suggesting the brain’s internal priorities, such as hunger or perceived threat, can influence whether pain behaviors persist. Work published in Cell Reports documented time-specific and cell-type-specific plasticity in the amygdala as pain transitions from acute to chronic, with distinct neuronal populations and synaptic changes at each phase. (The specific Cell Reports paper is identifiable by its focus on amygdala neuronal subtype plasticity across neuropathic pain phases; no DOI is available for direct linking.) A Current Biology paper showed that a dopamine D2-receptor microcircuit connecting the nucleus accumbens shell and core is necessary and sufficient for pain chronification in mice. (That study can be located by its characterization of accumbal D2-receptor shell-to-core microcircuit dynamics in pain chronification; no DOI is available for direct linking.)
Taken together, these studies point toward a shared conclusion: chronic pain is not simply damage that refuses to heal. It is a learned brain state, encoded in specific, plastic circuits that can, in principle, be modified.
The gap between rats and patients
Every study described above was conducted in rodents. No human imaging data or clinical trial results currently confirm that the CGIC pathway operates the same way in people. A Nature news article summarizing the parabrachial hub research explicitly flagged species limitations and noted that translation to humans remains unknown. The distance between a rat sciatic nerve injury model and the lived experience of a person with chronic back pain, fibromyalgia, or complex regional pain syndrome is substantial, and bridging it will require years of additional work.
The relationship between the different circuits is also unresolved. The CGIC-to-somatosensory pathway, the spino-brain-spinal loop, the parabrachial hub, the amygdala plasticity findings, and the accumbal microcircuit all implicate the brain as the site where pain becomes chronic. But no single study has tested how these systems interact in real time. Whether the CGIC acts upstream of the parabrachial hub, or whether reward circuits in the nucleus accumbens amplify insular signals, remains an open question.
Even within the insular cortex story, important details are missing. The CGIC is only one subregion of the insula, a structure already implicated in emotion, body awareness, and decision-making. How its pain-related activity interacts with neighboring insular zones that process other body states has not been mapped. And the Colorado work examined animals at specific post-injury time points; whether the same pathway dominates months or years later, or whether other brain regions gradually take over, has not been tested.
What this could mean for treatment
Chemogenetic tools like DREADDs are powerful for dissecting circuits in a lab, but they are not ready-made treatments. Delivering viral vectors to precise cortical microregions and then controlling them with designer compounds raises safety, ethical, and regulatory questions that are far from resolved. Any eventual human therapy inspired by these findings would more likely take the form of small-molecule drugs targeting the relevant receptors, neuromodulation devices, or noninvasive brain stimulation techniques designed to approximate the same circuit-level effects.
For the millions of people managing chronic pain right now, the practical implications are still distant. These findings do not overturn current treatments or offer an immediate cure. Physical rehabilitation, cognitive-behavioral therapy, and existing medications remain the front line. But the research does reframe what those treatments may be doing when they work: nudging brain networks toward a less sensitized state, even if clinicians are not consciously targeting the CGIC or the somatosensory cortex.
Why reframing chronic pain as a circuit problem changes the research agenda
Perhaps the most important shift these studies offer is conceptual. For decades, chronic pain has been treated primarily as a problem at the injury site: a damaged nerve, an inflamed joint, a herniated disc. When imaging and exams come back normal, patients are often told the pain is psychological, a label that can feel dismissive and that fails to capture what is actually happening in the brain.
The emerging picture is more precise. Chronic pain appears to be a state maintained by identifiable, physical circuits in the cortex, brainstem, and spinal cord. The CGIC-to-somatosensory pathway, the spino-brain-spinal loop, and the other hubs described in this research are early, detailed examples of how that state is wired into neural hardware. As more of the circuitry is mapped and human studies catch up to the animal work, the hope is that this mechanistic clarity will lead to treatments that are more targeted, longer-lasting, and less dependent on the trial-and-error approach that defines chronic pain care today.
That future is not here yet. But the gating mechanism, at least in rats, has been found. Researchers describe it metaphorically as a “switch” or “decision point,” shorthand for a complex set of synaptic and circuit-level changes rather than a literal physical toggle. The next question is whether scientists can learn to reach it in people.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
